- Home
- GLPG vs VICR Comparison
GLPG vs VICR Comparison
Compare GLPG & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- VICR
- Stock Information
- Founded
- GLPG 1999
- VICR 1981
- Country
- GLPG Belgium
- VICR United States
- Employees
- GLPG N/A
- VICR N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- VICR Industrial Machinery/Components
- Sector
- GLPG Health Care
- VICR Technology
- Exchange
- GLPG Nasdaq
- VICR Nasdaq
- Market Cap
- GLPG 1.8B
- VICR 2.1B
- IPO Year
- GLPG 2005
- VICR N/A
- Fundamental
- Price
- GLPG $26.49
- VICR $50.67
- Analyst Decision
- GLPG Sell
- VICR Hold
- Analyst Count
- GLPG 4
- VICR 2
- Target Price
- GLPG $25.33
- VICR $43.00
- AVG Volume (30 Days)
- GLPG 389.2K
- VICR 234.6K
- Earning Date
- GLPG 04-23-2025
- VICR 04-29-2025
- Dividend Yield
- GLPG N/A
- VICR N/A
- EPS Growth
- GLPG N/A
- VICR N/A
- EPS
- GLPG N/A
- VICR 0.14
- Revenue
- GLPG $311,493,731.00
- VICR $359,058,000.00
- Revenue This Year
- GLPG $0.08
- VICR $17.50
- Revenue Next Year
- GLPG $0.23
- VICR $14.54
- P/E Ratio
- GLPG N/A
- VICR $375.60
- Revenue Growth
- GLPG 18.32
- VICR N/A
- 52 Week Low
- GLPG $22.36
- VICR $30.90
- 52 Week High
- GLPG $31.23
- VICR $65.70
- Technical
- Relative Strength Index (RSI)
- GLPG 65.43
- VICR 54.71
- Support Level
- GLPG $24.31
- VICR $44.09
- Resistance Level
- GLPG $24.91
- VICR $47.55
- Average True Range (ATR)
- GLPG 0.83
- VICR 3.34
- MACD
- GLPG 0.27
- VICR 0.63
- Stochastic Oscillator
- GLPG 95.59
- VICR 96.23
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.